AstraZeneca has announced an ambitious plan to invest £50 billion in the United States by the end of the decade. This significant move is expected to bolster the company’s manufacturing
All posts tagged in pharmaceuticals3- Page
46Articles
Sir Pascal Soriot, the chief executive of AstraZeneca, Britain’s most valuable public company, has privately expressed his desire to relocate the pharmaceutical giant’s stock market listing to the United States,
Pascal Soriot, AstraZeneca’s chief executive, made waves at this year’s Boao Forum in China by boldly declaring the nation’s position as a key innovator in the pharmaceutical industry. His stance,
AstraZeneca, Britain’s largest pharmaceuticals company, has come under intense criticism after reports revealed the expansion of its operations in Russia, despite the ongoing war in Ukraine. Financial filings and investigative
British ministers are actively engaging with pharmaceutical companies regarding potential US tariffs, prompting calls for an emergency taskforce to safeguard medicine supplies. The UK government is working diligently to maintain
The pharmaceutical giant AstraZeneca has scrapped plans for a £450m expansion of its childhood flu vaccine manufacturing site in Speke, Merseyside, following protracted negotiations with the UK government over state
The recent decision by pharmaceutical giant AstraZeneca to abandon its £450 million investment plan in Liverpool has sparked serious concerns about Britain’s ability to attract and retain major corporate investments.
A critical £450 million investment by pharmaceutical giant AstraZeneca in a new vaccines facility in Speke, Liverpool, has encountered significant delays due to prolonged government deliberations on support measures. The
Novo Nordisk, the Danish pharmaceutical powerhouse, has invested hundreds of thousands of pounds in sponsorship deals with major UK pharmacy chains, including Boots and Lloyds, to enhance sales of its
British pharmaceutical giant AstraZeneca has distributed approximately £45 million to Russian healthcare professionals and organisations since the outbreak of the Ukraine war, despite mounting UK military support for Kyiv. The
Danish pharmaceutical giant Novo Nordisk witnessed a staggering $100 billion erosion in market value following disappointing results from its latest obesity drug trial. The company’s shares experienced their most significant
In a significant move strengthening its technological capabilities, AstraZeneca has appointed Arm Holdings Chief Executive Rene Haas to its board as a non-executive director, effective from next month. The appointment
AstraZeneca’s chief executive, Sir Pascal Soriot, has disclosed that former employees in China breached company protocols by using WeChat messaging services, amidst ongoing investigations by Chinese authorities. The revelation comes
British pharmaceutical giant GSK has held firm on its annual group forecasts despite experiencing a decline in vaccine sales, with strong performance in specialist medicines helping to offset the downturn.
